RxDoctor Payments Data

Liza Alexander Dean

Podiatry · Long Beach, CANPI 1053428078

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Among podiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,760in general payments, 2019–2025

Across 24 payments — averaging $73.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$408
  • Stryker$342
  • Paratek Pharmaceuticals, Inc.$228
  • Amgen$169
  • Abbott$150
  • Paragon 28, Inc.$134
  • plus $330 from 6 others

What the payments were for

  • Food & beverage$1,760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,760 in reported general payments places this provider in the 95th percentile of 136 podiatry providers in California.

See all podiatry providers in California

Medicare billing

Part B allowed, 2024
$42,140
Medicare patients
120
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole13$346
Allopurinol22$140
Mupirocin16$55
Cephalexin12$41

Paid to pharmacies, not to this prescriber.

Other podiatry in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →